Life Sciences industry

Unleash holistic innovation for improved health outcomes and shareholder value.

The life sciences industry faces increasing pressure to offer healthy returns to its investors by innovating new therapies. How do you build operational resilience and keep innovating in an increasingly complex landscape?

We can help you unleash the enterprise-wide power using the incisive strategy, functional expertise and scale.

We work with you to anticipate trends and bring perspectives to enable business strategy with technology and help your financial resiliency in a tax-efficient model. We can assist your growth strategy, both organically and through smart acquisitions. We can help improve your capital deployment toward better shareholder returns, so you can do what you do best: discover, develop and commercialize the most innovative therapies, devices and treatment modalities.

The EY Life Sciences team is presenting and participating in these industry conferences. Connect with us!

  • EY Webcast: Future of deals: Insights from the 2024 EY M&A Firepower Report (February 13, 2024 - 11:00 AM EST)

    Join our panel of industry leaders as we explore the findings from our 12th annual EY M&A Firepower report, “How life sciences can make the right deals in a time of change.” The year 2023 proved to be a “come back” year for life sciences deals, as we saw M&A investments climb by 51% to a total of US$215b at the end of 2023, an impressive return of big pharma to large-scale deals surpassing the historical average of US$200b. 

    In addition to discussing the trends and driving factors of 2023's dealmaking surge, our panelists will also provide insights and takeaways from the events during the J.P. Morgan Healthcare Conference week.

    Participation in this webcast is eligible for 1.2 CPE credits


    • Arda Ural, EY
    • Konstantina Katcheves, Bristol Myers Squibb  
    • Paris Panayiotopoulos, Blackstone
    • Subin Baral, EY

    February 13, 2024 - 11:00 AM EST

    *The on-demand replay will be available soon

  • BIO CEO and Investor Conference (February 26 – 27, 2024)

    Recognizing the Patterns in Strategic M&A during Down Markets

    With biotechnology stock indexes down nearly ten percent and little IPO appetite, companies’ access to fresh capital is particularly constrained, creating opportunities and challenges for those fortunate firms with enough capital to pursue M&A as valuations have declined.  Past biotechnology business cycles offer lessons, adjusted by recent clinical success trends, to identify critical success factors for strategic M&A for both the acquirer and acquired parties.  Learn from experienced deal makers about what types of M&A makes most sense in this market for keeping clinical pipelines active on behalf of patients when alternative capital sources are unavailable.


    • Arda Ural, PhD, EY (Moderator)
    • Gbola Amusa, MD, Chardan
    • Anna Kazanchyan, MD, Saghmos Therapeutics 
    • Chadé Severin, Skadden 
    • Mayukh Sukhatme, Roivant Sciences

    February 26, 2024 - 4:00 – 4:50 PM

    Learn more

  • Biocom Global Life Sciences Partnering & Investor Conference | La Jolla, CA (February 27 – 29, 2024)

    Bronze Sponsor

    February 27-29, 2024

    Learn more

  • DCAT Week | New York, NY (March 18 – 21, 2024)

    Research & Benchmarking Executive Summary: The Emerging Role of Artificial Intelligence (AI) in Supply Chain Management

    Gain expert views on the role of AI in sourcing and supply management—its potential, the types of projects and activities for which AI may be applied, and its challenges to use and adoption. This program will help bio/pharma companies and their suppliers understand how the adoption of AI will impact how they work together and how it might change their relationship.


    • Derron Stark, EY

    March 19, 2024 – 8:00 – 9:00 AM

    Learn more

  • LSI USA Emerging Medtech 2024 | Dana Point, CA (March 18 – 22, 2024)


    • John Babitt, EY
    • Jay Zhu, EY 

    Learn more

  • Point of Care NOW Industry Summit: Shaping the Future of Healthcare Marketing | New York, NY (March 20, 2024)



    • Jo Ann Saitta, EY 

    Learn more

  • Pharma USA | Philadelphia, PA (March 26 – 27, 2024)

    Propel launch and personalization: Install effective data strategies

    • Create a data-driven launch strategy playbook and leverage insights to optimize launches
    • Refine marketing and personalization strategies through incorporating new engagement data from customers
    • Extract more from your data investments and create competitive advantage from an internal data marketplace 


    • Jo Ann Saitta, EY
    • Ozgun Demir, Genentech
    • Alessandra De Almeida, Merck
    • Abigail Canlas, Otsuka Pharm

    March 26, 2024 – 2:40 – 3:20 PM

    Learn more

  • Informa Connect Life Sciences Accounting and Reporting Congress | Philadelphia, PA (March 26 – 28, 2024)

    Insights from the CFO

    Panel Discussion

    Insights from the CFO

    • How the current economic landscape has influenced profit pools
    • Stabilization of pricing and evolving trends within the generic marketplace
    • The role of CFOs in M&A, business development, and collaborations
    • External communications and investor relations to provide qualitative insights


    • Nick Cernese, EY
    • Susan Blum, Melinta

    March 27, 2024 - 11:15 - 12:00 PM EST

    Learn more

    Product Launch Readiness: Accounting policy, operational accounting & financial reporting considerations


    Product Launch Readiness: Accounting policy, operational accounting & financial reporting considerations Speakers 

    • Phil Howard, EY
    • Ashish Mandelia, Mersana
    • Angelina Pigna, Mirati

    March 27, 2024 - 01:45 - 02:30 PM EST

    Learn more

    Navigating the Evolving Role of the Controller


    Navigating the Evolving Role of the Controller

    • Crucial elements for consideration as the role of the controller continues to evolve
    • Digitization impacting controllership
    • Fund raising, collaborations, business development and acquisitions 

    Navigating the Evolving Role of the Controller Speakers:

    • Mark Solak, EY
    • Matthew Busch, Amgen
    • Scott Godsoe, Takeda
    • Samantha Prout, Amicus
    • Blair Davis, Spark
    • Rita Karachun, Merck

    March 28, 2024 - 10:45 - 11:45 AM EST

    Learn more

Direct to your inbox

Stay up to date with our latest health care and life sciences insights.


Health Sciences & Wellness

Know the key steps in building the Health Care and Life Sciences industry of the future.

Learn more

Health Care industry

Explore the latest trends impacting innovation in the health care industry.

Learn more

How can we help?

Contact us to know how EY can support your Life Sciences organization.